ProfileGDS4718 / 1555794_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 3% 2% 2% 3% 6% 8% 1% 5% 5% 5% 7% 1% 5% 2% 4% 3% 3% 3% 7% 3% 4% 3% 8% 4% 4% 5% 3% 2% 7% 3% 4% 3% 4% 4% 5% 4% 2% 2% 5% 5% 2% 4% 1% 6% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.487983
GSM549102patient 115, normal, homogenized [OPG study]3.461212
GSM549104patient 119, normal, homogenized [OPG study]3.387222
GSM549108patient 138, normal, homogenized [OPG study]3.500483
GSM549119patient 077, normal, homogenized [OPG study]3.619336
GSM549133patient 032, cancer, homogenized [OPG study]3.668798
GSM549139patient 042, cancer, homogenized [OPG study]3.252721
GSM549099patient 107, normal, homogenized [OPG study]3.591885
GSM549109patient 139, normal, homogenized [OPG study]3.60665
GSM549110patient 046, normal, homogenized [OPG study]3.57085
GSM549114patient 063, normal, homogenized [OPG study]3.64577
GSM549122patient 082, normal, homogenized [OPG study]3.389151
GSM549134patient 033, cancer, homogenized [OPG study]3.584075
GSM549136patient 036, cancer, homogenized [OPG study]3.415332
GSM549140patient 044, cancer, homogenized [OPG study]3.516564
GSM549111patient 047, normal, homogenized [OPG study]3.474453
GSM549113patient 057, normal, homogenized [OPG study]3.46373
GSM549132patient 031, cancer, homogenized [OPG study]3.47813
GSM549137patient 038, cancer, homogenized [OPG study]3.656467
GSM549142patient 047, cancer, homogenized [OPG study]3.486143
GSM549100patient 110, normal, homogenized [OPG study]3.553634
GSM549107patient 135, normal, homogenized [OPG study]3.464713
GSM549115patient 068, normal, homogenized [OPG study]3.675688
GSM549116patient 072, normal, homogenized [OPG study]3.543294
GSM549120patient 078, normal, homogenized [OPG study]3.531914
GSM549131patient 030, cancer, homogenized [OPG study]3.570115
GSM549118patient 074, normal, homogenized [OPG study]3.516013
GSM549129patient 027, cancer, homogenized [OPG study]3.439622
GSM549123patient 088, normal, homogenized [OPG study]3.689537
GSM549124patient 006, cancer, homogenized [OPG study]3.503343
GSM549126patient 015, cancer, homogenized [OPG study]3.504354
GSM549128patient 025, cancer, homogenized [OPG study]3.480363
GSM549103patient 117, normal, homogenized [OPG study]3.559974
GSM549117patient 073, normal, homogenized [OPG study]3.570484
GSM549138patient 041, cancer, homogenized [OPG study]3.557935
GSM549141patient 045, cancer, homogenized [OPG study]3.511234
GSM549130patient 028, cancer, homogenized [OPG study]3.407792
GSM549101patient 111, normal, homogenized [OPG study]3.389842
GSM549105patient 128, normal, homogenized [OPG study]3.57775
GSM549106patient 134, normal, homogenized [OPG study]3.536825
GSM549112patient 048, normal, homogenized [OPG study]3.442732
GSM549125patient 011, cancer, homogenized [OPG study]3.535994
GSM549127patient 024, cancer, homogenized [OPG study]3.332231
GSM549135patient 035, cancer, homogenized [OPG study]3.594576